136 related articles for article (PubMed ID: 629247)
1. Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors.
Yolken RH; Hilgartner MW
Am J Dis Child; 1978 Mar; 132(3):291-3. PubMed ID: 629247
[TBL] [Abstract][Full Text] [Related]
2. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
Buchanan GR; Kevy SV
Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
Abildgaard CF; Britton M; Harrison J
J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
[TBL] [Abstract][Full Text] [Related]
4. Increased fibrinopeptide A after prothrombin complex concentrates.
Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
Barthels M
Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
[TBL] [Abstract][Full Text] [Related]
7. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
Sonoda T; Solomon A; Krauss S; Cruz P; Jones FS; Levin J
Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
[TBL] [Abstract][Full Text] [Related]
8. Treatment of anti-factor VIII antibodies.
Blatt PM; White GC; McMillan CW; Roberts HR
Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
[TBL] [Abstract][Full Text] [Related]
9. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
Kelly P; Penner JA
JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
[TBL] [Abstract][Full Text] [Related]
10. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.
Lusher JM
Semin Hematol; 1994 Apr; 31(2 Suppl 4):49-52. PubMed ID: 7939776
[TBL] [Abstract][Full Text] [Related]
11. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
Diniz MJ; Dias Francisco F; Tavares ML; Leal I
Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
[TBL] [Abstract][Full Text] [Related]
12. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
Blatt PM; Ménaché D; Roberts HR
Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with factor VIII inhibitors.
Lusher JM
Transfus Med Rev; 1987 Aug; 1(2):123-30. PubMed ID: 2980269
[TBL] [Abstract][Full Text] [Related]
14. The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors.
Lusher JM
Scand J Haematol Suppl; 1984; 40():195-202. PubMed ID: 6433452
[No Abstract] [Full Text] [Related]
15. The effect of non-activated prothrombin complex concentrate (Proplex ST) on intraperitoneal hematoma in a hemophilia A patient with a factor VIII inhibitor.
Kagawa H; Yasuzawa M; Ozaki Y; Yamamoto Y; Katsurada T; Nomura S; Okubo S; Fukuhara S
Intern Med; 1996 Apr; 35(4):319-22. PubMed ID: 8739790
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
17. [Suppression of factor VIII inhibitor in children with hemophilia A].
Zenz W; Muntean W
Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
[TBL] [Abstract][Full Text] [Related]
18. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
20. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
